Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

In Vitro Fertilization Market to Reach USD 36.39 Billion by 2026; Rising Adoption of IVF Techniques to Favor Growth, states Fortune Business Insights™

Published

on

Pune, June 18, 2020 (GLOBE NEWSWIRE) — The global in vitro fertilization market is expected to reach USD 36.39 billion by 2026, exhibiting a CAGR of 10.1% during the forecast period. The increasing cases of infertility can be a critical factor bolstering the growth of the market during the forecast period, states Fortune Business Insights in a report titled “In Vitro Fertilization Market Size, Share & Industry Analysis, By Type (Conventional IVF, and IVF with ICSI), By Procedure (Fresh Non-donor, Frozen Non-donor, Fresh Donor, and Frozen Donor), By End User (Hospitals, and Fertility Clinics) and Regional Forecast, 2019-2026” the market size stood at USD 16.89 billion in 2018.The whole world is battling with the novel coronavirus. The governments of several countries have instigated lockdown to thwart the spread of this deadly virus. Such plans have caused disturbances in the production and supply chain. But, with time and resolution, we will be able to combat this stern time and get back to normality. Our well-revised reports will help companies to receive in-depth information about the present scenario of every market so that you can adopt the necessary strategies accordingly.Through analysis of all the sections in the marketInformative data and figuresMarket trends and driversSuperior insights into all emerging developmentsRegional data in terms of revenueThe emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
To get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/in-vitro-fertilization-ivf-market-102189
Increasing Demand for ICSI treatment to Augment GrowthThe growing awareness about infertility will spur demand for the treatment of IVF in the forthcoming years. The growing introduction of advanced treatment of intracytoplasmic sperm injection (ICSI) will drive the market in the foreseeable future. The rising medicinal and surgical procedures for IVF treatment will enable speedy expansion of the market. IVF is the process of fertilization by extracting eggs, retrieving a sperm sample, and then manually combining egg and sperm in a laboratory.The rising adoption of the IVF technique among infertile couples will subsequently create lucrative opportunities for the market during the forecast period. The rising emphasis on assisted reproductive techniques will boost the demand of the market. The increasing popularity of IVF & ICSI treatment is likely to foster the growth of the in vitro fertilization market.Market Restraint:High Risks Of IVF Treatment to Limit Market GrowthThe high risks associated with IVF and ICSI treatment will subsequently limit the growth of the market during the forecast period. For instance, according to a data published by the Reproductive Science Center, a rare condition called “Imprinting Disorders” associated with IVF procedures estimated that the risk of such disorders with IVF treatment was around 2 to 5 per 15,000 births using IVF technique, while the risk in general cases was 1 in 15,000 normal births. Thus, the potential risks and birth defects associated with IVF treatment and high-priced treatment of IVF are factors expected to dampen the growth of the market during the forecast period.Rising Prevalence of Infertility to Aid Expansion in EuropeThe market in Europe generated a revenue of USD 7.57 billion in 2018. The growth in the region is attributed to the increasing prevalence of infertility. The growing success rate of IVF treatment countries such as Spain and Denmark will further aid the development of the market in Europe. According to data published by the European Society of Human Reproduction and Embryology (ESHRE) states that the pregnancy rate per treatment in Europe in 2016 was around 30.5% which witnessed a growth of 1.3% than the previous year owing to the high success rate of IVF & ICSI procedures.The market in Asia Pacific is expected to grow rapidly during the forecast period owing to the surge in medical tourism. The rising awareness regarding infertility will have a tremendous impact on the market in the region. The higher adoption of IVF treatment will consequently foster the growth of the market in the forthcoming years. For instance, according to the Fertility Society of Australia, in 2018 there were around 120 registered clinics present in Australia, among which almost 98.0% were providing IVF services.Key Development:May 2019: NMC Health plc, announced that it has acquired a majority of stake in Boston IVF to create the most diversified and experienced fertility network in the world.May 2019: Scientists of Monash unveiled a new embryo screening test to reduce the risk of miscarriage during IVF treatment.
List of the leading Companies Profiled in the IVF Market are:
Boston IVF
Monash IVFPelargos IVFOvation Fertility
RSMCShady Grove Fertility
Group Ambroise Paré ClinicBangkok IVF center
Bloom IVF CentreOther Service ProvidersIntroductionResearch ScopeMarket SegmentationResearch MethodologyDefinitions and AssumptionsExecutive SummaryMarket DynamicsMarket DriversMarket RestraintsMarket OpportunitiesKey InsightsPrevalence of Infertility, For Key Country/Region, 2018Number of IVF Procedures, For Key Country/Regions, 2018Number of Registered Fertility Clinics, For Key Countries, 2018Reimbursement Scenario, For Key Country/RegionKey Industry Developments, Partnerships, Mergers and AcquisitionGlobal In Vitro Fertilization Market Analysis, Insights and Forecast, 2015-2026Key Findings / SummaryMarket Analysis, Insights and Forecast – By TypeConventional IVFIVF with ICSIMarket Analysis, Insights and Forecast – By ProcedureFresh Non-donorFrozen Non-donorFresh DonorFrozen DonorMarket Analysis, Insights and Forecast – By End UserHospitalsFertility ClinicsMarket Analysis, Insights and Forecast – By RegionNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaTOC Continued….!!!

Request for Customization:
https://www.fortunebusinessinsights.com/enquiry/customization/in-vitro-fertilization-ivf-market-102189
Assisted Reproductive Technology (ART) Market Size, Share & Industry Analysis, By Technique (In-Vitro Fertilization (IVF), Artificial Insemination (AI-IUI), Frozen Embryo Transfer (FET), and Others), By Procedure (Fresh Donor, Fresh Non-donor, Frozen Donor, and Frozen Non-donor), By End User (Fertility Clinics, and Hospitals) and Regional Forecast, 2019-2026Fetal Bovine Serum Market Size, Share and Global Trend By Application (Drugs discovery, In-vitro fertilization, Vaccine production, Cell-based research, Diagnostics and biopharmaceutical manufacturing, Others), By End Users (Pharmaceutical & biotechnology companies, Contract Research Organizations (CRO), Academic and research organizations, Others) and Geography Forecast till 2026
Biomaterials Market Size, Share and Industry Analysis, By Material (Metallic, Ceramic, Polymers, and Natural), By Application (Cardiovascular, Dental, Orthopedic, Plastic Surgery, Urology, Gastroenterology, and Others), and Regional Forecast, 2020-2027
Magnetic Resonance Imaging Equipment Market Size, Share & Industry Analysis, By Strength (Less than 1.5 T, 1.5 T, and More than 1.5 T), By Application (Musculoskeletal, Neurology, Cardiology, Body Imaging, and Others), By End User (Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers), and Regional Forecast, 2019-2027
Nuclear Medicine/ Radiopharmaceuticals Market Size, Share & Industry Analysis, By Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), By Application (Neurology, Cardiology, Oncology, and Others), By End User (Hospitals & Clinics, Diagnostic Centers, and Others) and Regional Forecast, 2019-2026Negative Pressure Wound Therapy (NPWT) Market Size, Share & Industry Analysis, By Device Type (Conventional NPWT, and Single-use NPWT), By Indication (Diabetic Foot Ulcers, Pressure Ulcers, Burns & Trauma, and Others), By End User (Hospitals, Clinics, Homecare Settings, and Others) and Regional Forecast, 2019-2026Human Papillomavirus (HPV) Vaccines Market Size, Share & Industry Analysis, By Type (Bivalent and Polyvalent), By Disease Indication (HPV Associated Cancer and Genital Warts), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others) and Geography Forecast, 2019-2026Bovine Lactoferrin Market Size, Share, Trends & Industry Analysis, By Product (Spray-dried, and Freeze-dried), By Application (Infant Formula, Pharmaceuticals, Dietary Supplements, Food, and Others), and Regional Forecast 2019-2026

About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/in-vitro-fertilization-ivf-market-9606

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

IDTechEx Forecasts Durable, Engineered CO2 Removals Will Reach 630 Mt by 2044

Published

on

idtechex-forecasts-durable,-engineered-co2-removals-will-reach-630-mt-by-2044

BOSTON, May 13, 2024 /PRNewswire/ — Carbon dioxide removal (CDR) will be needed to reach any international net zero emission targets and avoid global warming beyond 1.5-2°C. Negative emissions technologies (NETs), especially those that go beyond nature-based approaches to provide long-lasting scalable CO2 removals, have therefore been receiving increased support through government policy and voluntary carbon credit purchases from corporations with ambitious climate goals. IDTechEx predicts that by 2044, the world’s capacity for such durable, engineered CO2 removals will exceed 630 megatonnes per annum.

The new IDTechEx report, “Carbon Dioxide Removal (CDR) 2024-2044: Carbon Credit Markets, Technologies, Players, and Forecasts”, provides a comprehensive outlook of the emerging CDR industry and carbon credit markets, with an in-depth analysis of the technological, economic, regulatory, and environmental aspects that are shaping this market. In it, IDTechEx focuses on technologies that actively draw CO₂ from the atmosphere and sequester it into carbon sinks, namely:
Direct air carbon capture and storage (DACCS), which leverages chemical processes to capture CO₂ directly from the air and sequester it in geologic formations or durable products.Biomass with carbon removal and storage (BiCRS), which involves strategies that use biomass to remove CO2 from the atmosphere and store it underground or in long-lived products. It includes approaches such as BECCS (bioenergy with carbon capture and storage), biochar, biomass burial, and bio-oil underground injection.Nature-based CDR methods that leverage biological processes to increase carbon stocks in soils, forests, and other terrestrial ecosystems, i.e., afforestation/reforestation and soil carbon sequestration techniques.Mineralization NETs that enhance natural mineral processes that permanently bind CO₂ from the atmosphere with rocks through enhanced rock weathering, carbonation of mineral wastes, and oxide looping.Ocean-based CDR methods that strengthen the ocean carbon pump through ocean alkalinity enhancement, direct ocean capture, artificial upwelling/downwelling, coastal blue carbon, algae cultivation/marine seaweed sinking, and ocean fertilization.TRL (technology readiness level) chart of carbon dioxide removal technologies covered in the IDTechEx report. Source: IDTechEx
These CDR technologies are at vastly different stages of readiness. Some are nearly ready for large-scale deployment, while others require basic scientific research and further field trials.
Durable, engineered removals versus nature-based CDR solutions
Afforestation/reforestation solutions have historically dominated the supply of CDR due to their low cost and high maturity. However, demand for this type of removal carbon credit has been dropping in voluntary markets over the past few years due to several high-profile scandals and the low durability/permanence associated with nature-based CDR. Instead, corporate buyers have increasingly turned towards highly durable, engineered carbon removal credits generated from approaches such as DACCS and BECCS. These removals offer credible climate action but have a high price tag and are in short supply. Most durable engineered approaches are yet to be included in compliance markets and, therefore, rely on pre-purchases from corporate buyers for early-stage commercial development.
The new IDTechEx report, “Carbon Dioxide Removal (CDR) 2024-2044: Carbon Credit Markets, Technologies, Players, and Forecasts”, provides insights into the most promising technologies being developed in CDR, highlighting the pros and cons of each method, examining key drivers and barriers for growth, and comparing the removal potential, capture cost, and durability of all technologies. Despite capacity currently being limited, there has been much interest in DACCS as a solution to permanently remove CO₂ from the atmosphere and reverse climate change. DACCS is immediate, measurable, allows for permanent storage, can be located practically anywhere, is likely to cause minimal ecosystem impacts, and can achieve large-scale removals.
However, the rate at which DACCS can be scaled up is likely a limiting factor. The challenges of deploying DACCS include the large energy inputs (requiring substantial low-carbon energy resources), the high cost, and the sorbent requirements. The industry is aiming for the ambitious target of gigatonne-scale of DACCS removals by 2050. To make this happen, corporate action, investments, policy shapers, and regulatory guidelines need to come together to bring down the costs.
Although BECCS is currently the most mature and widely deployed durable engineered CDR technology, scale-up has historically been slow, and planned capacity is modest. Despite the technologies behind BECCS being relatively mature, there is a risk that using biomass for CO₂ removal and storage may compete with agricultural land and water or negatively impact biodiversity and conservation. IDTechEx analysis has indicated that BECCS has a large potential to contribute to climate change mitigation, though not at the scale assumed in some models due to economic and environmental risk factors. 
Comprehensive analysis and market forecasts
IDTechEx’s “Carbon Dioxide Removal (CDR) 2024-2044: Carbon Credit Markets, Technologies, Players, and Forecasts” report assesses the CDR carbon credit market in detail, evaluating the different technologies, latest advancements, and potential adoption drivers and barriers. The report also includes a granular forecast until 2044 for the deployment of nine NET categories (DACCS, BECCS, biochar, biomass burial, direct ocean capture, ocean alkalinity enhancement, seaweed sinking, enhanced rock weathering, and carbonation of minerals) alongside exclusive analysis and interview-based company profiles.
Some of the key questions answered in this report:
What are the requirements (energy, land, water, feedstocks, supply chain) for the deployment of CDR methods?What is the climate impact of implementing CDR on a large scale?Which gaps (technological, regulatory, business model) need to be addressed to enable each NET?What is the status of CDR within compliance markets and voluntary carbon credit markets, and what is the market potential?What are the key drivers and hurdles for CDR market growth?How much do CDR solutions cost today and may cost in the future?Who are the key players in the CDR space?What is needed to further develop the CDR sector?To find out more about this report, including downloadable sample pages, please visit www.IDTechEx.com/CDR.
For the full portfolio of energy and decarbonization market research from IDTechEx, please see www.IDTechEx.com/Research/Energy.
Upcoming free-to-attend webinar
Carbon Credit Markets: The Rise of Durable, Engineered, Carbon Dioxide Removal Technologies
Eve Pope, Technology Analyst at IDTechEx and author of this article, will be presenting a free-to-attend webinar on the topic on Wednesday 5 June 2024 – Carbon Credit Markets: The Rise of Durable, Engineered, Carbon Dioxide Removal Technologies.
This webinar will reveal insights into the CDR space, and its content includes:
Importance of carbon dioxide removal in reaching global net-zero emissions targets.Overview of all negative emission technologies (NETs): Direct air carbon capture and storage (DACCS), Biomass with carbon removal and storage (BiCRS), Nature-based CDR methods, Mineralization NETs, and ocean-based CDR approachesContextualization of CDR within carbon markets and how voluntary carbon credits are accelerating NETs in the short-termIdentifying the key factors driving the market pivot from nature-based solutions such as afforestation/reforestation to durable, engineered, CDR approachesDiscussion of environmental, technical, and economic drivers/barriers for DACCS and BECCSPlease click here to check timings and register for your specific time zone.
If you are unable to make the date, please register anyway to receive the links to the on-demand recording (available for a limited time) and webinar slides as soon as they are available.
About IDTechEx:IDTechEx provides trusted independent research on emerging technologies and their markets. Since 1999, we have been helping our clients to understand new technologies, their supply chains, market requirements, opportunities and forecasts. For more information, contact [email protected] or visit www.IDTechEx.com. 
Image download:https://www.dropbox.com/scl/fo/w3qrp6k8jbmv52mtuhh5c/AOrw0woUk9gdCyotkWU1NaY?rlkey=gruj58ayfta125a92ofygonof&st=l0h7gs83&dl=0 
Media Contact:Lucy RogersSales and Marketing [email protected] +44(0)1223 812300
Social Media Links:Twitter: www.twitter.com/IDTechExLinkedIn: www.linkedin.com/company/IDTechEx
Logo – https://mma.prnewswire.com/media/478371/IDTechEx_Logo.jpgPhoto – https://mma.prnewswire.com/media/2411525/IDTechEx_TRL.jpg

View original content:https://www.prnewswire.co.uk/news-releases/idtechex-forecasts-durable-engineered-co2-removals-will-reach-630-mt-by-2044-302144001.html

Continue Reading

Artificial Intelligence

Department of Health – Abu Dhabi Unveils ‘Declaration of Principles’ on Bioconvergence to Enhance Global Healthcare Outcomes

Published

on

department-of-health-–-abu-dhabi-unveils-‘declaration-of-principles’-on-bioconvergence-to-enhance-global-healthcare-outcomes

ABU DHABI, UAE, May 13, 2024 /PRNewswire/ — An an outcome of the Health Leaders Forum (HLF) organised during Abu Dhabi Global Healthcare Week (ADGHW), the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, unveiled a Declaration of Principles on Bioconvergence, to transform healthcare, improve human health and well-being. As a first-of-its-kind initiative, the Declaration outlines global principles covering guidance on transparency, accountability, and bias mitigation, as well as research ethics and ethical decision-making in the field of Bioconvergence.

Bioconvergence has been recognised as the latest technological trend of the 21st century for the healthcare sector. It is a transdisciplinary field that merges engineering and life sciences, and is set to revolutionise the health-tech industry. Bioconvergence fuses life sciences with a vast number of technologies from fields such as mathematics, engineering, and physical and computational sciences.
The Declaration of Principles will witness leading local and global entities collaborate with DoH including Amazon, Microsoft, UAE University (UAEU), Mohammad Bin Zayed University for AI (MBZUAI), Core 42 and Masdar City. Segmented into six strategic pillars, the principles aim to advance Bioconvergence research and development, encourage investment in the field to address urgent healthcare challenges, establish international cooperation frameworks, prioritise research areas in public health and personalised medicine, and promote the adoption of advanced technologies such as Artificial Intelligence (AI) and nanomedicine.
Dr. Asma Ibrahim Al Mannaei, the Executive Director of the Research and Innovation Centre at the Department of Health – Abu Dhabi (DoH): “In the intricacies of Bioconvergence, establishing fundamental principles is not merely a choice, but a collective responsibility. These principles serve as a beacon of transparency, guardians of accountability and shields against any form of bias. With the ever-evolving intersection of health and technology, integrity and diligence remain guiding threads for the Department of Health – Abu Dhabi. Reinforcing Abu Dhabi’s position as a leading destination for innovation in healthcare, the unique Declaration serves as a testament to the Department’s continued efforts to build a healthier world and shape the future of healthcare for generations to come.”
Moreover, upholding ethical standards and responsible practices involve raising awareness on the benefits and risks of Bioconvergence technologies, establishing ethical guidelines, and ensuring accessibility and affordability for all. Investment in education and workforce development entails supporting skill development, integrating Bioconvergence into relevant curricula, fostering interdisciplinary collaboration, and promoting diversity in the field.
Additionally, fostering collaboration and the exchange of knowledge among stakeholders, advocating for supportive policies and regulations, and engaging the community through awareness campaigns and transparent communication are crucial steps in advancing Bioconvergence research and innovation while maintaining community’s trust and support. These key pillars will support accelerating the future of healthcare and life sciences by making quality health a global priority.
Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council, Abu Dhabi Global Healthcare Week is a major government initiative taking place between 13 and 15 May 2024. ADGHW seeks to accelerate collaboration, innovation, and investment, and bring together researchers, policymakers, healthcare specialists, investors, and entrepreneurs across the global healthcare and life science ecosystem.
For more information please visit: https://www.adghw.com/
About Department of Health – Abu Dhabi (DoH):
The DoH is the regulatory body of the healthcare sector at the Emirate of Abu Dhabi and ensures excellence in healthcare by monitoring the health status of the population. DoH defines the strategy for the health system, monitors and analyses the health status of the population and performance of the system. In addition, DoH shapes the regulatory framework for the health system, inspects against regulations, enforce standards, and encourages adoption of world-class best practices and performance targets by all healthcare service providers in the Emirate. DoH also drives programmes to increase awareness and adoption of healthy living standards among the residents of the Emirate of Abu Dhabi in addition to regulating scope of services, premiums and reimbursement rates of the health system.
For further information on DoH, visit https://www.doh.gov.ae/ and follow on X, Instagram, Facebook, LinkedIn and YouTube.
Photo – https://mma.prnewswire.com/media/2411144/DoH_Abu_Dhabi.jpg

View original content:https://www.prnewswire.co.uk/news-releases/department-of-health–abu-dhabi-unveils-declaration-of-principles-on-bioconvergence-to-enhance-global-healthcare-outcomes-302143829.html

Continue Reading

Artificial Intelligence

Advanced HPC Server Platforms by MiTAC and TYAN Spotlighted at ISC High Performance 2024

Published

on

advanced-hpc-server-platforms-by-mitac-and-tyan-spotlighted-at-isc-high-performance-2024

HAMBURG, Germany, May 13, 2024 /PRNewswire/ — Today, the subsidiary of MiTAC Holdings Corp.(TSE:3706), MiTAC Computing Technology and its server brand TYAN®, the leading manufacturer in server platform design worldwide, bring their new server platforms to the ISC 2024 event, booth #B01 in Hamburg, Germany. These solutions harness the power of the latest AMD EPYC 9004 series and AMD Ryzen 7000 series, along with the 5th Gen Intel Xeon Scalable Processors, offering optimized performance for HPC needs.

MiTAC introduces its revolutionary lineup of DSG products
Driven by shared values, MiTAC and Intel have had a strong partnership for years. Last year, MiTAC took over the manufacturing and sales of products designed by Intel Datacenter Solution Group (DSG). Today, MiTAC presents two models from its DSG product lineups, which are from the Intel Server M50FCP Family and the Intel Server D50DNP Family, at ISC 2024.
First, MiTAC displays a multi-node server, the Intel Server System D50DNP1MHEVAC 1U Half-Width air-cooled compute module with EVAC heatsink from the Intel Server D50DNP Family (Denali Pass). Intel® Server D50DNP family is the highest-performance density server featuring 5th/4th Gen Intel® Xeon® Scalable Processors or the Intel® Xeon® CPU Max Series and purpose-built modules, delivering robust performance, efficiency, and scalability tailored to specific needs for AI computing.
Then, there is the 1U Intel Server System M50FCP1UR204 from the Intel Server M50FCP Family (Fox Creek Pass). Supporting 5th/4th Gen Intel® Xeon® Scalable processors, the general purpose Intel® Server M50FCP Family offers robust compute capabilities, integrated accelerators, and exceptional I/O and memory bandwidth, making it the perfect solution for handling data-intensive mainstream tasks.
TYAN brings HPC optimized servers at ISC 2024
The Transport CX TD76-B8058 is a 2U 4-node single-socket HCI server powered by AMD EPYC 9004 processors. Each node includes 16 DDR5-4800 DIMM slots, 4 hot-swappable E1.s drive bays, 2 NVMe M.2 slots, 1 OCP v3.0 LAN mezzanine slot, and 1 standard PCIe 5.0 x16 slot. Front I/O facilitates efficient network cable routing, while rear-accessible hot-swappable cooling fans and redundant 80+ Titanium power supplies ensure optimal system serviceability.  Powered by 5th/4th Gen Intel Xeon Scalable processor, TYAN Thunder CX TD76-B5658 is a 2U 4 nodes single-socket server designed for high-density cloud server deployment. It comes with shared system fans, redundant 80+ Titanium power supplies, and hot-swappable modules for simple maintenance. Additionally, it offers front I/O for effortless network cable management, and each node supports PCIe 5.0 x16, OCP v3.0 LAN mezzanine, and NVMe E1.s SSDs.
Apart from the above, TYAN provides the Transport CX GX40-B8016 for those requiring entry-level servers. This compact 1U AMD Ryzen cloud server is perfect for front-end portal and edge computing tasks in data centers. It features 4 DDR5-4800 UDIMM slots, supports up to 4 SATA drives, 2 NVMe M.2 slots, and one PCIe 5.0 x16 slot.
About MiTAC Computing Technology Corp.
MiTAC Computing Technology Corp, a MiTAC Holdings Corp. (TSE:3706) subsidiary, specializes in cloud and edge computing solutions and has over 30 years of design and manufacturing expertise. With a strong focus on large-scale data centers, the company offers flexible and customized supply models for various systems and applications. Its product lineup includes TYAN servers, 5G ORAN servers, high-performance AI servers, and data center products. Intel Datacenter Solutions Group (DSG) transited its business to MiTAC since July 2023, allowing MiTAC expanding its product offerings with cutting-edge total cost of ownership solutions for next-gen data center equipment.
MiTAC Computing Technology Official website: www.mitacmct.com
MiTAC DSG website: https://datacentersolutions.mitacmct.com/
About TYAN
TYAN, as a leading server brand of MiTAC Computing Technology Corporation under the MiTAC Holdings Corp. (TSE:3706), designs, manufactures and markets advanced x86 and x86-64 server/workstation board technology, platforms and server solution products. Its products are sold to OEMs, VARs, System Integrators and Resellers worldwide for a wide range of applications. TYAN enables its customers to be technology leaders by providing scalable, highly-integrated, and reliable products for a wide range of applications such as server appliances and solutions for HPC, hyper-scale/data center, server storage, AI and security appliance markets. For more information, please visit TYAN’s website at http://www.tyan.com or MiTAC Computing Technology Corporation website at http://www.mitacmct.com
AMD, the AMD Arrow logo, EPYC, Ryzen and combinations thereof are trademarks of Advanced Micro Devices, Inc.
Intel, the Intel logo, Xeon and combinations thereof are trademarks of Intel Corporation
Photo – https://mma.prnewswire.com/media/2408826/2024_ISC_PR.jpg

View original content:https://www.prnewswire.co.uk/news-releases/advanced-hpc-server-platforms-by-mitac-and-tyan-spotlighted-at-isc-high-performance-2024-302141236.html

Continue Reading

Trending